Loading…
Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40
Protozoa of the genus Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with L. major in mice indicates that a protective immune response is achieved...
Saved in:
Published in: | Immunology Letters 2006-05, Vol.105 (1), p.38-47 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383 |
---|---|
cites | |
container_end_page | 47 |
container_issue | 1 |
container_start_page | 38 |
container_title | Immunology Letters |
container_volume | 105 |
creator | Hernández S., Mayra Xiomara Barçante, Thales Augusto Vilela, Luciano Tafuri, Wagner Luiz Afonso, Luís Carlos Crocco Vieira, Leda Quercia |
description | Protozoa of the genus
Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with
L. major in mice indicates that a protective immune response is achieved when Th1 cells are developed. Thus, adoptive or vaccine-induced protection against leishmaniasis is largely dependent on cell-mediated immunity and IFN-γ production. Induction of a Th1 response is dependent on the presence of IL-12 whilst lymphocytes are activated. This study was aimed at evaluating the role of IL-12 during infection with
L. amazonensis and after vaccination with Leishvacin
® (killed
Leishmania amazonensis promastigotes), since the role of this cytokine in vaccine-induced immunity with this preparation in experimental models or in humans is not yet elucidated. Hence, C57BL/6 interleukin-12-deficient mice (IL-12p40
−/−) and wild-type controls (wt) were infected with
L. amazonensis and the course of infection, parasite burden and cytokine production were compared. IL-12p40
−/− mice were more susceptible to
L. amazonensis than wt: lesions and parasite burden were larger in IL-12p40
−/− when compared to wt. Interestingly, IL-4 was not produced in the absence of IL-12 in response to infection with
L. amazonensis. To evaluate the role of IL-12 in the vaccine-induced immunity against
L. amazonensis infection, IL-12p40
−/− wt mice were vaccinated in the base of the tail and subsequently challenged with
L. amazonensis in the footpads. Surprisingly, vaccinated IL-12p40
−/− mice developed smaller lesions and had fewer parasites in footpads than non-vaccinated controls. Lymph node and spleen cells from vaccinated IL-12p40
−/− mice did not produce high levels of IFN-γ in response do in vitro stimulus with antigen. Hence, partial protection against infection with
L. amazonensis could be obtained in the absence of functional IL-12 and a typical Th1 response. |
doi_str_mv | 10.1016/j.imlet.2005.12.002 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67963859</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165247805003883</els_id><sourcerecordid>17178813</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383</originalsourceid><addsrcrecordid>eNqFkUFLJDEQhYO4OKPrLxAkJ2_dJpWkO33wIOKuwoCX3b2GdLriZJhOj50ewf31ZpwBbwoFdfneK-o9Qi44Kznj1fWqDP0apxIYUyWHkjE4InOu66ZgSsIxmWdKFSBrPSOnKa0Y40pIcUJmvJJVpTmbE_fPOhciFiF2W4cd3YzDhG4KQ6T22YaYJrrAkJa9jcFS29v_Q8SYQqJ5hnbKSFaFSKclUtsmjA7p4OnjouBwDWIj2U_yw9t1wvPDPiN_f93_uXsoFk-_H-9uF4WTQkxF5UE2qKRXYL2wFqQWIFqPDXQWvPO6dh3UulEATrUVl8iEh7rhvkMUWpyRq71v_uFli2kyfUgO12sbcdgmU9VNJbRqvgV5zWutucig2INuHFIa0ZvNGHo7vhnOzK4EszIfJZhdCYaDySVk1eXBftv22H1qDqln4GYPYE7jNeBokgu74Low5uxNN4QvD7wDZ7yYnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17178813</pqid></control><display><type>article</type><title>Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40</title><source>Wiley</source><source>Elsevier</source><source>PubMed Central</source><creator>Hernández S., Mayra Xiomara ; Barçante, Thales Augusto ; Vilela, Luciano ; Tafuri, Wagner Luiz ; Afonso, Luís Carlos Crocco ; Vieira, Leda Quercia</creator><creatorcontrib>Hernández S., Mayra Xiomara ; Barçante, Thales Augusto ; Vilela, Luciano ; Tafuri, Wagner Luiz ; Afonso, Luís Carlos Crocco ; Vieira, Leda Quercia</creatorcontrib><description>Protozoa of the genus
Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with
L. major in mice indicates that a protective immune response is achieved when Th1 cells are developed. Thus, adoptive or vaccine-induced protection against leishmaniasis is largely dependent on cell-mediated immunity and IFN-γ production. Induction of a Th1 response is dependent on the presence of IL-12 whilst lymphocytes are activated. This study was aimed at evaluating the role of IL-12 during infection with
L. amazonensis and after vaccination with Leishvacin
® (killed
Leishmania amazonensis promastigotes), since the role of this cytokine in vaccine-induced immunity with this preparation in experimental models or in humans is not yet elucidated. Hence, C57BL/6 interleukin-12-deficient mice (IL-12p40
−/−) and wild-type controls (wt) were infected with
L. amazonensis and the course of infection, parasite burden and cytokine production were compared. IL-12p40
−/− mice were more susceptible to
L. amazonensis than wt: lesions and parasite burden were larger in IL-12p40
−/− when compared to wt. Interestingly, IL-4 was not produced in the absence of IL-12 in response to infection with
L. amazonensis. To evaluate the role of IL-12 in the vaccine-induced immunity against
L. amazonensis infection, IL-12p40
−/− wt mice were vaccinated in the base of the tail and subsequently challenged with
L. amazonensis in the footpads. Surprisingly, vaccinated IL-12p40
−/− mice developed smaller lesions and had fewer parasites in footpads than non-vaccinated controls. Lymph node and spleen cells from vaccinated IL-12p40
−/− mice did not produce high levels of IFN-γ in response do in vitro stimulus with antigen. Hence, partial protection against infection with
L. amazonensis could be obtained in the absence of functional IL-12 and a typical Th1 response.</description><identifier>ISSN: 0165-2478</identifier><identifier>EISSN: 1879-0542</identifier><identifier>EISSN: 1365-2567</identifier><identifier>DOI: 10.1016/j.imlet.2005.12.002</identifier><identifier>PMID: 16466810</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adjuvant ; Animals ; Female ; IL-12 ; Interferon-gamma - biosynthesis ; Interleukin-12 - deficiency ; Interleukin-12 - genetics ; Interleukin-12 Subunit p40 ; Interleukin-4 - biosynthesis ; Leishmania ; Leishmania amazonensis ; Leishmania mexicana - immunology ; Leishmaniasis ; Leishmaniasis, Cutaneous - immunology ; Leishmaniasis, Cutaneous - pathology ; Leishmaniasis, Cutaneous - prevention & control ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Knockout ; Parasite ; Protein Subunits - deficiency ; Protein Subunits - genetics ; Protozoa ; Protozoan Vaccines - pharmacology ; Vaccine</subject><ispartof>Immunology Letters, 2006-05, Vol.105 (1), p.38-47</ispartof><rights>2006 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16466810$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hernández S., Mayra Xiomara</creatorcontrib><creatorcontrib>Barçante, Thales Augusto</creatorcontrib><creatorcontrib>Vilela, Luciano</creatorcontrib><creatorcontrib>Tafuri, Wagner Luiz</creatorcontrib><creatorcontrib>Afonso, Luís Carlos Crocco</creatorcontrib><creatorcontrib>Vieira, Leda Quercia</creatorcontrib><title>Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40</title><title>Immunology Letters</title><addtitle>Immunol Lett</addtitle><description>Protozoa of the genus
Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with
L. major in mice indicates that a protective immune response is achieved when Th1 cells are developed. Thus, adoptive or vaccine-induced protection against leishmaniasis is largely dependent on cell-mediated immunity and IFN-γ production. Induction of a Th1 response is dependent on the presence of IL-12 whilst lymphocytes are activated. This study was aimed at evaluating the role of IL-12 during infection with
L. amazonensis and after vaccination with Leishvacin
® (killed
Leishmania amazonensis promastigotes), since the role of this cytokine in vaccine-induced immunity with this preparation in experimental models or in humans is not yet elucidated. Hence, C57BL/6 interleukin-12-deficient mice (IL-12p40
−/−) and wild-type controls (wt) were infected with
L. amazonensis and the course of infection, parasite burden and cytokine production were compared. IL-12p40
−/− mice were more susceptible to
L. amazonensis than wt: lesions and parasite burden were larger in IL-12p40
−/− when compared to wt. Interestingly, IL-4 was not produced in the absence of IL-12 in response to infection with
L. amazonensis. To evaluate the role of IL-12 in the vaccine-induced immunity against
L. amazonensis infection, IL-12p40
−/− wt mice were vaccinated in the base of the tail and subsequently challenged with
L. amazonensis in the footpads. Surprisingly, vaccinated IL-12p40
−/− mice developed smaller lesions and had fewer parasites in footpads than non-vaccinated controls. Lymph node and spleen cells from vaccinated IL-12p40
−/− mice did not produce high levels of IFN-γ in response do in vitro stimulus with antigen. Hence, partial protection against infection with
L. amazonensis could be obtained in the absence of functional IL-12 and a typical Th1 response.</description><subject>Adjuvant</subject><subject>Animals</subject><subject>Female</subject><subject>IL-12</subject><subject>Interferon-gamma - biosynthesis</subject><subject>Interleukin-12 - deficiency</subject><subject>Interleukin-12 - genetics</subject><subject>Interleukin-12 Subunit p40</subject><subject>Interleukin-4 - biosynthesis</subject><subject>Leishmania</subject><subject>Leishmania amazonensis</subject><subject>Leishmania mexicana - immunology</subject><subject>Leishmaniasis</subject><subject>Leishmaniasis, Cutaneous - immunology</subject><subject>Leishmaniasis, Cutaneous - pathology</subject><subject>Leishmaniasis, Cutaneous - prevention & control</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Parasite</subject><subject>Protein Subunits - deficiency</subject><subject>Protein Subunits - genetics</subject><subject>Protozoa</subject><subject>Protozoan Vaccines - pharmacology</subject><subject>Vaccine</subject><issn>0165-2478</issn><issn>1879-0542</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNqFkUFLJDEQhYO4OKPrLxAkJ2_dJpWkO33wIOKuwoCX3b2GdLriZJhOj50ewf31ZpwBbwoFdfneK-o9Qi44Kznj1fWqDP0apxIYUyWHkjE4InOu66ZgSsIxmWdKFSBrPSOnKa0Y40pIcUJmvJJVpTmbE_fPOhciFiF2W4cd3YzDhG4KQ6T22YaYJrrAkJa9jcFS29v_Q8SYQqJ5hnbKSFaFSKclUtsmjA7p4OnjouBwDWIj2U_yw9t1wvPDPiN_f93_uXsoFk-_H-9uF4WTQkxF5UE2qKRXYL2wFqQWIFqPDXQWvPO6dh3UulEATrUVl8iEh7rhvkMUWpyRq71v_uFli2kyfUgO12sbcdgmU9VNJbRqvgV5zWutucig2INuHFIa0ZvNGHo7vhnOzK4EszIfJZhdCYaDySVk1eXBftv22H1qDqln4GYPYE7jNeBokgu74Low5uxNN4QvD7wDZ7yYnw</recordid><startdate>20060515</startdate><enddate>20060515</enddate><creator>Hernández S., Mayra Xiomara</creator><creator>Barçante, Thales Augusto</creator><creator>Vilela, Luciano</creator><creator>Tafuri, Wagner Luiz</creator><creator>Afonso, Luís Carlos Crocco</creator><creator>Vieira, Leda Quercia</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20060515</creationdate><title>Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40</title><author>Hernández S., Mayra Xiomara ; Barçante, Thales Augusto ; Vilela, Luciano ; Tafuri, Wagner Luiz ; Afonso, Luís Carlos Crocco ; Vieira, Leda Quercia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adjuvant</topic><topic>Animals</topic><topic>Female</topic><topic>IL-12</topic><topic>Interferon-gamma - biosynthesis</topic><topic>Interleukin-12 - deficiency</topic><topic>Interleukin-12 - genetics</topic><topic>Interleukin-12 Subunit p40</topic><topic>Interleukin-4 - biosynthesis</topic><topic>Leishmania</topic><topic>Leishmania amazonensis</topic><topic>Leishmania mexicana - immunology</topic><topic>Leishmaniasis</topic><topic>Leishmaniasis, Cutaneous - immunology</topic><topic>Leishmaniasis, Cutaneous - pathology</topic><topic>Leishmaniasis, Cutaneous - prevention & control</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Parasite</topic><topic>Protein Subunits - deficiency</topic><topic>Protein Subunits - genetics</topic><topic>Protozoa</topic><topic>Protozoan Vaccines - pharmacology</topic><topic>Vaccine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hernández S., Mayra Xiomara</creatorcontrib><creatorcontrib>Barçante, Thales Augusto</creatorcontrib><creatorcontrib>Vilela, Luciano</creatorcontrib><creatorcontrib>Tafuri, Wagner Luiz</creatorcontrib><creatorcontrib>Afonso, Luís Carlos Crocco</creatorcontrib><creatorcontrib>Vieira, Leda Quercia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Immunology Letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hernández S., Mayra Xiomara</au><au>Barçante, Thales Augusto</au><au>Vilela, Luciano</au><au>Tafuri, Wagner Luiz</au><au>Afonso, Luís Carlos Crocco</au><au>Vieira, Leda Quercia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40</atitle><jtitle>Immunology Letters</jtitle><addtitle>Immunol Lett</addtitle><date>2006-05-15</date><risdate>2006</risdate><volume>105</volume><issue>1</issue><spage>38</spage><epage>47</epage><pages>38-47</pages><issn>0165-2478</issn><eissn>1879-0542</eissn><eissn>1365-2567</eissn><abstract>Protozoa of the genus
Leishmania are intracellular parasites of macrophages and may cause diverse clinical forms of leishmaniasis, including cutaneous, diffuse cutaneous, mucocutaneous and visceral leishmaniasis. Infection with
L. major in mice indicates that a protective immune response is achieved when Th1 cells are developed. Thus, adoptive or vaccine-induced protection against leishmaniasis is largely dependent on cell-mediated immunity and IFN-γ production. Induction of a Th1 response is dependent on the presence of IL-12 whilst lymphocytes are activated. This study was aimed at evaluating the role of IL-12 during infection with
L. amazonensis and after vaccination with Leishvacin
® (killed
Leishmania amazonensis promastigotes), since the role of this cytokine in vaccine-induced immunity with this preparation in experimental models or in humans is not yet elucidated. Hence, C57BL/6 interleukin-12-deficient mice (IL-12p40
−/−) and wild-type controls (wt) were infected with
L. amazonensis and the course of infection, parasite burden and cytokine production were compared. IL-12p40
−/− mice were more susceptible to
L. amazonensis than wt: lesions and parasite burden were larger in IL-12p40
−/− when compared to wt. Interestingly, IL-4 was not produced in the absence of IL-12 in response to infection with
L. amazonensis. To evaluate the role of IL-12 in the vaccine-induced immunity against
L. amazonensis infection, IL-12p40
−/− wt mice were vaccinated in the base of the tail and subsequently challenged with
L. amazonensis in the footpads. Surprisingly, vaccinated IL-12p40
−/− mice developed smaller lesions and had fewer parasites in footpads than non-vaccinated controls. Lymph node and spleen cells from vaccinated IL-12p40
−/− mice did not produce high levels of IFN-γ in response do in vitro stimulus with antigen. Hence, partial protection against infection with
L. amazonensis could be obtained in the absence of functional IL-12 and a typical Th1 response.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>16466810</pmid><doi>10.1016/j.imlet.2005.12.002</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0165-2478 |
ispartof | Immunology Letters, 2006-05, Vol.105 (1), p.38-47 |
issn | 0165-2478 1879-0542 1365-2567 |
language | eng |
recordid | cdi_proquest_miscellaneous_67963859 |
source | Wiley; Elsevier; PubMed Central |
subjects | Adjuvant Animals Female IL-12 Interferon-gamma - biosynthesis Interleukin-12 - deficiency Interleukin-12 - genetics Interleukin-12 Subunit p40 Interleukin-4 - biosynthesis Leishmania Leishmania amazonensis Leishmania mexicana - immunology Leishmaniasis Leishmaniasis, Cutaneous - immunology Leishmaniasis, Cutaneous - pathology Leishmaniasis, Cutaneous - prevention & control Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Knockout Parasite Protein Subunits - deficiency Protein Subunits - genetics Protozoa Protozoan Vaccines - pharmacology Vaccine |
title | Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A06%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vaccine-induced%20protection%20against%20Leishmania%20amazonensis%20is%20obtained%20in%20the%20absence%20of%20IL-12/23p40&rft.jtitle=Immunology%20Letters&rft.au=Hern%C3%A1ndez%20S.,%20Mayra%20Xiomara&rft.date=2006-05-15&rft.volume=105&rft.issue=1&rft.spage=38&rft.epage=47&rft.pages=38-47&rft.issn=0165-2478&rft.eissn=1879-0542&rft_id=info:doi/10.1016/j.imlet.2005.12.002&rft_dat=%3Cproquest_cross%3E17178813%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c433t-6f249e54f52af3aa248323bfe92da2fcf87cd2789522c5b614e03f2791fdee383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17178813&rft_id=info:pmid/16466810&rfr_iscdi=true |